Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy

Enterotoxigenic E. coli (ETEC) and Shigella are enteropathogens causing significant global morbidity and mortality, particularly in low-income countries. No licensed vaccine exists for either pathogen, but candidates are in development, with the most advanced candidates potentially approaching pivot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosangadi, Divya, Smith, Peter G., Giersing, Birgitte K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892262/
https://www.ncbi.nlm.nih.gov/pubmed/29031690
http://dx.doi.org/10.1016/j.vaccine.2017.09.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892262/
https://www.ncbi.nlm.nih.gov/pubmed/29031690
http://dx.doi.org/10.1016/j.vaccine.2017.09.083

Ejemplares similares